Article
N,N-Dimethylacetamide Targets Neuroinflammation in Alzheimer’s Disease in In-vitro and Ex-vivo Models
2022-12-20
Abstract excerpt
Alzheimer’s disease (AD) is a chronic degenerative brain disorder with no clear pathogenesis or effective cure, accounting for 60–80% cases of dementia. In recent years, the importance of neuroinflammation in the pathogenesis of AD and other neurodegenerative disorders has come into focus. Previously, we made the serendipitous discovery that the widely used drug excipient N,N-dimethylacetamide (DMA) attenuates end...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 24bc45fd-246a-573a-831f-afcb7378eb0c
- DOI
- 10.21203/rs.3.rs-2363746/v1
